Some of my favorite stocks have become much cheaper recently, but ETFs remain a big focus of my investment strategy.

This ETF isn't as heralded as its larger relatives, but it's one to watch this month, and it could be a star next year.

The exchange-traded fund (ETF) industry has grown in all directions in 2025. ETFs have become a prominent investment in a ...

Investors shopping for top exchange-traded funds (ETFs) can't be blamed if they're focusing on funds holding equities ...

Here are three reasons why it could be a smart move to add the Betashares Nasdaq 100 ETF (ASX: NDQ) to your portfolio in ...

The Vanguard High-Yield Active ETF (NYSEMKT: VGHY) is a surprise entrant into the Vanguard lineup, given its decades-long ...

The Nasdaq 100 Index held steady last week as it rose close to its all-time high of $26,145. It has risen by over 7.76% from ...

The exchange-traded fund industry is booming right now. Investors are flocking towards ETFs, and they’ve become one of the ...

VGT is missing key tech stocks because of how they're categorized by sector. Nvidia, Microsoft, and Apple account for over 45 ...

The Betashares Nasdaq 100 ETF offers Australian investors an accessible way to gain exposure to leading technology giants and innovative sectors, which are highly influential in global markets.

Amid the trying circumstances in the market right now, investors may be well served to target the best biotech ETFs to buy. Fundamentally, these exchange-traded funds benefit from permanent relevance.

Nasdaq’s International Securities Exchange proposed quadrupling the daily trading limit for options tied to BlackRock Inc.’s iShares Bitcoin Trust ETF as demand from investors increases.